Invesco
FRTX

Invesco’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Invesco’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-166
Closed -$617K – 4325
2013
Q4 		$617K Buy
166
+31
+23% +$117K ﹤0.01% 3361
2013
Q3 		$531K Buy
135
+42
+45% +$315K ﹤0.01% 3372
2013
Q2 		$916K Buy
+93
New +$1.03M ﹤0.01% 2927

Other funds holding FRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Invesco's FRTX Position: Q1 2014 in Review

Invesco sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q1 2014, closing a stake of 166 shares — an estimated $617K sold.

Invesco first reported a position in FRTX in Q2 2013 and held it in 3 quarters. The position peaked at $916K in Q2 2013. 78 funds tracked by Wall St. Rank hold FRTX as of Q1 2014.

  • Invesco reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q1 2014 after selling out during the quarter.
  • Invesco sold 166 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q1 2014, an estimated $617K.
  • Invesco first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 3 quarters.
  • Invesco's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $916K in Q2 2013.
  • 78 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q1 2014.

Based on Invesco's 13F filing for Q1 2014, filed 15 May 2014.